학술논문
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder
Document Type
Article
Author
Source
In European Neuropsychopharmacology August 2018 28(8):970-979
Subject
Language
ISSN
0924-977X